The levels of TNF-alpha in cerebrospinal fluid and serum do not correlate with the counts of the white blood cells in acute phase of ischaemic stroke

Folia Morphologica

Volumn 60, Issue 2, 2001, Pages 91-97

  Zaremba, J ^a   Losy, J ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

CSF; Serum; Stroke; Tumour necrosis factor alpha; White blood cells

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MALE;

ACUTE DISEASE; AGED; BRAIN ISCHEMIA; CEREBROSPINAL FLUID; FEMALE; HUMANS; LEUKOCYTES; MALE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034991794     PISSN: 00155659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Leukocyte endothelial interactions and regulation of leukocyte migration
2. Human tumor necrosis factor: Production, purification and characterization
3. Cerebrovascular reactivity: Role of endothelium/platelet/leukocyte interactions
4. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells
5. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin-1
6. Endothelial-leukocyte adhesion molecules
7. Increase in vascular permeability induced by leukotriene B4 and the role of polymorphonuclear leukocytes
8. Epidemiology of stroke
9. Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model
10. Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat
11. Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic and complement pathways
12. Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis
13. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome
14. Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases
15. Leukocytes and the risk of ischemic diseases
16. Increased cytokine release from peripheral blood cells after acute stroke
17. Influx of leukocytes and platelets in an evolving brain infarct/Wistar rat
18. Cellular localization of tumor necrosis factor alpha following focal cerebral ischemia in mice
19. Granulocyte adhesion, deformability, and superoxide formation in acute stroke
20. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period
21. Stroke risk factors prepare brainstem tissues for modified local Shwartzman reaction
22. Lipopolysaccharide-induced production of tumor necrosis factor activity in rats with and without risk factors for stroke
23. Cytokines, macrophages, and leukocytes in brain ischemia
24. ICAM-1 expression on human brain microvascular endothelial cells
25. Lymphocytic infiltration and expression of intercelullar adhesion molecule-1 in photochemically induced ischemia of the rat cortex
26. Deficiency of intercellular adhesion molecule 1 attenuates microcirculatory disturbance and infarction size in focal cerebral ischemia
27. Neurochemistry of stroke
28. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees
29. Cell adhesion molecule mediates endothelial cell injury caused by activated neutrophils
30. Modulation of endothelial cell hemostatic properties by tumor necrosis factor
31. Studies on the fibronectin receptors of human peripheral blood leukocytes: Morphologic and functional characterization
32. Imaging of leukocytic infiltration in human cerebral infarcts
33. Peripheral white blood cell count in cerebral ischemic infarction
34. Leukocyte counts and cerebrovascular disease
35. Histopathologic clues to the pathways of neuronal death following ischemia/hypoxia
36. Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation
37. Leukocyte count and aggregation during the evolution of cerebral ischemic injury
38. Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto rats
39. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
40. Ultrastructural localization of hippocampal TNF-alpha immunoreactive cells in rats following transient global ischemia
41. Induction of tumor necrosis factor-alpha in the mouse hippocampus following transient forebrain ischemia
42. Leukocyte response in patients suffering from acute stroke
43. The influence of exogenous fibronectin on blood granulocyte adherence to vascular endothelium in vitro
44. Induced expression of adhesion molecules following focal brain ischemia
45. Thrombomodulin expression in bovine brain capilaries. Anticoagulant function of the blood-brain barrier, regional differences and regulatory mechanisms
46. Interleukins and tumor necrosis factor in inflammation
47. Tissue destruction by neutrophils
48. Inhibition of TNF-alpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain
49. Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice
50. Tumour necrosis factor-alpha is increased in cerebrospinal fluid and serum of ischaemic stroke patients and correlates with the volume of evolving brain infarct
51. Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat
52. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons